Evidence map›Paper›PMID 30027425›Full record

ArticleJournal of inherited metabolic disease2018

Outcome measures for children with mitochondrial disease: consensus recommendations for future studies from a Delphi-based international workshop.

Saskia Koene, Lara van Bon, Enrico Bertini, Cecilia Jimenez-Moreno, Lianne van der Giessen, Imelda de Groot, Robert McFarland, Sumit Parikh, Shamima Rahman, Michelle Wood and 3 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Journal of inherited metabolic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Use of genotypic HIV DNA testing: a DELPHI-type consensus.The Journal of antimicrobial chemotherapy · 2024
    Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Moving towards clinical trials for mitochondrial diseases.Journal of inherited metabolic disease · 2021
    Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Saskia KoeneRadboud Center for Mitochondrial Medicine, Department of Paediatrics, Radboudumc, Nijmegen, The Netherlands. Saskia.koene@radboudumc.nl.ORCID 0000-0002-9876-744X
Lara van BonRadboud Center for Mitochondrial Medicine, Department of Paediatrics, Radboudumc, Nijmegen, The Netherlands.
Enrico BertiniUnit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Research Hospital, Rome, Italy.
Cecilia Jimenez-MorenoWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Lianne van der GiessenCenter for Lysosomal and Metabolic Diseases and Department of Pediatric Physiotherapy, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
Imelda de GrootRadboud Center for Mitochondrial Medicine, Department of Paediatrics, Radboudumc, Nijmegen, The Netherlands.
Robert McFarlandWellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Sumit ParikhMitochondrial Medicine Center, Neuroscience Institute, Cleveland Clinic, Cleveland, OH, USA.
Shamima RahmanMitochondrial Research Group, UCL Great Ormond Street Institute of Child Health and Metabolic Unit, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
Michelle WoodMitochondrial Research Group, UCL Great Ormond Street Institute of Child Health and Metabolic Unit, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
Jiri ZemanDepartment of Paediatrics, First Faculty of Medicine and General Faculty Hospital, Prague, Czech Republic.
Anjo JanssenRadboud Center for Mitochondrial Medicine, Department of Paediatrics, Radboudumc, Nijmegen, The Netherlands.
Jan SmeitinkRadboud Center for Mitochondrial Medicine, Department of Paediatrics, Radboudumc, Nijmegen, The Netherlands.
Radboud University Nijmegen · NLGreat Ormond Street Hospital for Children NHS Foundation Trust · GBWellcome Centre for Mitochondrial Research · GBBambino Gesù Children's Hospital · ITCleveland Clinic · USErasmus MC - Sophia Children’s Hospital · NLGeneral University Hospital in Prague · CZ

Funding

Department of Health
6 · The paper itself

Abstract

Although there are no effective disease-modifying therapies for mitochondrial diseases, an increasing number of trials are being conducted in this rare disease group. The use of sensitive and valid endpoints is essential to test the effectiveness of potential treatments. There is no consensus on which outcome measures to use in children with mitochondrial disease. The aims of this two-day Delphi-based workshop were to (i) define the protocol for an international, multi-centre natural history study in children with mitochondrial myopathy and (ii) to select appropriate outcome measures for a validation study in children with mitochondrial encephalopathy. We suggest two sets of outcome measures for a natural history study in children with mitochondrial myopathy and for a proposed validation study in children with mitochondrial encephalopathy.

Indexed as

Delphi TechniqueChildConsensusHumansInternationalityMitochondrial EncephalomyopathiesMitochondrial MyopathiesMulticenter Studies as TopicMuscle DevelopmentTreatment OutcomeValidation Studies as Topic

Identifiers

PMID30027425
PMCPMC6326961
OpenAlexW2884886514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.